Replies to post #112943 on Biotech Values

[jq1234]

Merck Serono Europe Limited Withdraws its Marketing Authorisation Application for Movectro (cladribine)

LONDON, Feb. 17, 2011--The European Medicines Agency has been formally notified by Merck Serono Europe Limited of its decision to withdraw its application for a centralised marketing authorisation for the medicine Movectro (cladribine), 10 mg tablets.

http://pharmalive.com/News/index.cfm?articleid=762339